Ozempic May Decrease Opioid Overdose Risk, Study Suggests
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.
Ozempic May Decrease Opioid Overdose Risk, Study Suggests: What To Know
Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent opioid overdoses.”
Study: Ozempic might lower risk of opioid overdose
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people's risk of opioid overdose. People with Type 2 diabetes prescribed semaglutide (Ozempic,
Ozempic Reduced Opioid Overdose Risk, Research Shows
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study that adds to a growing body of evidence suggesting it may help manage addiction.
Could Ozempic Help Prevent Opioid Overdoses?
WEDNESDAY, Sept. 25, 2024 (HealthDay News) -- In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.
Who’s Really Keeping Ozempic and Wegovy Prices So High?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
BioSpace16h
Novo’s Ozempic Seen as Shoo-In for Next Round of Medicare Price Negotiations
Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet for the list of the next 15 drugs whose Medicare prices ...
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Novo Nordisk CEO Faces Senate Questions Over High Prices Of Ozempic And Wegovy In US
Novo Nordisk CEO Lars Fruergaard Jorgensen testified before the Senate Health, Education, Labor and Pensions Committee hearing in ...
Novo Nordisk CEO Defends Ozempic Price In Senate Testimony
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...